<DOC>
	<DOCNO>NCT02435550</DOCNO>
	<brief_summary>The purpose study use genomic information individual patient create simulation avatar use predict novel drug combination therapeutic potential .</brief_summary>
	<brief_title>iCare Cancer Patients</brief_title>
	<detailed_description>As part normal clinical care , subject undergo peripheral blood draw biopsy disease assessment cancer . In case hematological malignancy , bone marrow aspiration &amp; biopsy routinely perform . As part project , follow do sample collect clinical outcome data : - donate peripheral blood specimen whenever blood already draw clinical purpose . - donate bone marrow aspiration sample whenever bone marrow aspiration procedure already do clinical purpose . - allow investigator perform gene mutation profile . - allow investigator study gene mutation result . - allow investigator perform pharmacogenetic profiling . - allow investigator study pharmacogenetic profile . - allow investigator examine chromosome copy number variation . - allow investigator examine genomic methylation . - allow investigator quantify metabolomics/cytokines .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>Individuals know suspected blood cancer hematologic disorder Capable providing inform consent . Does blood cancer hematologic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>